NCT00501371 - MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

MCS

soft-gel capsule, 15 mg/cap., Qd, 12 weeks

DRUG

Placebo

soft-gel capsule, Qd, 12 weeks

Trial Locations (5)

National Taiwan University Hospital, Taipei

China Medical University Hospital, Taichung

Chang Gung Memorial Hospital, Chiayi City

Chung-Ho Memorial Hospital,Kaohsiung Medical University, Kaohsiung City

Kaohsiung Veterans General Hospital, Kaohsiung City